MAD2L1 and lung carcinoma: Semiquantitative RT-PCR shows that mitotic arrest defective protein 2 (MAD2) is overexpressed in a high percentage of lung cancers, and multivariate analysis suggests that high-level MAD2 can be a prognostic marker independently [39].